Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Clinical trial NCT02607930 · COMPLETED
Trial details
- NCT number
- NCT02607930
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-13
- Primary completion
- 2017-05-09
- Enrollment
- 631
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.